IPOs under microscope as Chr Hansen and Life get ready
The EMEA IPO market will face a stern test next week when Danish biotech firm Chr Hansen and South African healthcare group Life price their IPOs, which together hope to raise around $1.8bn.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: